COVID-19 associated pulmonary aspergillosis (CAPA): An added potential burden on India's pre-existing fungal superinfection.
Clin Epidemiol Glob Health
; 13: 100960, 2022.
Article
en En
| MEDLINE
| ID: mdl-35005301
ABSTRACT
The ongoing pandemic that initiated in Wuhan, China, has been an international public health emergency since January 2020. India has been battling a brutal COVID-19's second wave since April 2021. The healthcare system was struggling with a substantial increase in COVID-19 cases when the lack of necessary resources further aroused a major setback. Opportunistic fungal infections, specifically mucormycosis and candidiasis have become a pressing matter of concern. Recent cases of aspergillosis have also heightened public alarm. Hence, call for an immediate response to this public health crisis is the need of the hour by establishing countrywide surveillance, diagnostic, and management system, as well as public awareness to alleviate the burden of COVID-19 and fungal infections in India.
Antimicrobial stewardship; Aspergillosis; CAPA, COVID-19 Associated Pulmonary Aspergillosis; CDC, Centers for Disease Control and Prevention; CFR, Case Fatality Ratio; COVID-19; COVID-19, Coronavirus disease 2019; HCWs, healthcare workers; ICU, Intensive care units; India; Public health crises; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WHO, World Health Organization
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Tipo de estudio:
Risk_factors_studies
Idioma:
En
Revista:
Clin Epidemiol Glob Health
Año:
2022
Tipo del documento:
Article
País de afiliación:
Pakistán